Otsuka America Pharmaceutical, Inc., Earns Designation as a Great Place to Work-Certified™ Company In 2020
Otsuka is Lead, Founding Sponsor of PBS’ WELL BEINGS Youth Mental Health Project, Featuring Ken Burns Documentary Series
Otsuka Announces Positive Top-line Results from Two Phase 3 Studies of Centanafadine for the Treatment of Attention-deficit Hyperactivity Disorder (ADHD) in Adult Patients
Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Otsuka Pharmaceutical Development & Commercialization, Inc. Launches NephU, an Online Healthcare Community Dedicated to Kidney Health
Otsuka America Pharmaceutical, Inc., Purchases the Assets of Proteus Digital Health, Inc.
Sozosei Foundation Announces Donations of $439,000 to Support Those with Mental Health and Kidney Diseases
Otsuka Announces No-Cost Access to its Medicines for Eligible, Newly Uninsured Patients in the US